Hepatitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

US Panel Recommends New Adult Vaccine Against Hepatitis B - U.S. News & World Report



U.S. News & World Report
 
US Panel Recommends New Adult Vaccine Against Hepatitis B 
U.S. News & World Report
This undated photo provided by Dynavax on February 2018 shows vials of the Heplisav-B vaccine. It was licensed in the U.S., in November 2017 and is the first new hepatitis B vaccine in 25 years. (Ryan Skinner/Dynavax via AP) The Associated Press. By ...
Dynavax stock rises after hepatitis B vaccine recommendation by CDC immunization committee MarketWatch
CDC panel approves new hepatitis B vaccine for adults UPI.com
ACIP Recommends Use of Heplisav-B for Hepatitis B Prevention in Adults Monthly Prescribing Reference
Nasdaq 
all 13 news articles » 


Kentucky links Hepatitis A outbreak cases to others in California and Utah - Food Safety News



Food Safety News
 
Kentucky links Hepatitis A outbreak cases to others in California and Utah 
Food Safety News
Homeless people and drug users are apparently experiencing the brunt of Kentucky's uptick in hepatitis A virus cases. The Kentucky Department of Public Health (KDPH) has charted the increase since Jan. 1, 2017, with 103 confirmed cases, which have ...

 


Lawmakers urge HHS to sidestep patents on hepatitis C drugs - STAT



STAT
 
Lawmakers urge HHS to sidestep patents on hepatitis C drugs 
STAT
U.S. Rep. Elijah Cummings (D-Md.), who has regularly questioned drug prices, is one of those who signed the letter. Chip Somodevilla/Getty Images. Twitter · Facebook · LinkedIn · Email · Doximity · Republish; Print. I. n a bid to address the high cost ...

 


Hepatitis A - Pipeline Insight, 2018 - ResearchAndMarkets.com - Business Wire (press release)



Hepatitis A - Pipeline Insight, 2018 - ResearchAndMarkets.com 
Business Wire (press release)
The 'Hepatitis A - Pipeline Insight, 2018' report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis A development. The report provides detailed coverage of the pipeline ...

 


Kentucky officials say outbreak of Hepatitis A has hit Louisville - WDRB



WDRB
 
Kentucky officials say outbreak of Hepatitis A has hit Louisville 
WDRB
LOUISVILLE, Ky. (WDRB) -- A rare virus has become an outbreak in Louisville -- and now there's a new effort to stop it from spreading. The Kentucky Department for Public Health declared an outbreak of acute Hepatitis A in November, with the majority of ...

 


Hepatitis A case confirmed at Novi Red Lobster - Detroit News - The Detroit News



The Detroit News
 
Hepatitis A case confirmed at Novi Red Lobster - Detroit News 
The Detroit News
Officials warning customers at Red Lobster in 27700 block of Novi between Jan. 14 - Feb. 14 might have been exposed.
Hepatitis A confirmed in Novi Red Lobster employee The Oakland Press
Hepatitis A case located at restaurant in Oakland County MLive.com
Michigan posts 25th hepatitis A death; restaurant worker sick | Food ... Food Safety News
WXYZ  -CBS Detroit 
all 13 news articles » 


NICE nod for Gilead's pan-genotypic hepatitis C therapy - PharmaTimes



PharmaTimes
 
NICE nod for Gilead's pan-genotypic hepatitis C therapy 
PharmaTimes
Gilead's pan-genotypic treatment for hepatitis C Vosevi has won the National Institute for Health and Care Excellence's seal of approval for use on the NHS. Vosevi (sofosbuvir/velpatasvir/voxilaprevir; SOF/VEL/VOX) was cleared by European regulators in ...

 


China seeks better Hepatitis C treatment - Xinhua



China seeks better Hepatitis C treatment 
Xinhua
BEIJING, Feb. 21 (Xinhua) -- China increased its pace of development of new treatments for Hepatitis C in support of the World Health Organization goal of eliminating viral hepatitis by 2030. Zhuang Hui of the Chinese Academy of Engineering and ...

and more » 


Gilead wins reversal of $2.54B hepatitis C patent verdict, but Merck ... - FiercePharma



FiercePharma
 
Gilead wins reversal of $2.54B hepatitis C patent verdict, but Merck ... 
FiercePharma
The latest victory in a years-long hepatitis C patent battle between Gilead Sciences and Merck goes to Gilead. On Friday, a federal judge overturned a $2.54 billion verdict against the biotech on grounds that a key Merck patent used to support the ...
Merck shares dip after surprise patent loss to Gilead MarketWatch
Gilead Sciences, Inc. - GILD - Stock Price Today - Zacks Zacks
SEC FORM 4 - SEC.gov SEC.gov

all 149 news articles » 


State asks pharmacists to help fight hepatitis A outbreak | Michigan ... - Michigan Radio



Michigan Radio
 
State asks pharmacists to help fight hepatitis A outbreak | Michigan ... 
Michigan Radio
The state is looking to pharmacists to help combat elevated cases of hepatitis A in Michigan. Last week, the Department of Health and Human Services sent a.
Michigan hepatitis A death toll now 25 - Outbreak News Today Outbreak News Today

all 2 news articles »